Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a leading platform for cell programming and biosecurity, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's Chief Financial Officer, Mark Dmytruk, is scheduled to engage in a fireside chat on Friday, September 6 at 11:30 a.m. ET. This event presents an opportunity for investors and interested parties to gain insights into Ginkgo Bioworks' financial strategies and market position. The company has stated that additional details, including a webcast link and replay of the fireside chat, will be made available on their investor relations website at https://investors.ginkgobioworks.com/events.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), una piattaforma leader nella programmazione cellulare e nella biosicurezza, ha annunciato la propria partecipazione alla 22ª Conferenza Annuale sulla Salute Globale di Morgan Stanley. Il Chief Financial Officer dell'azienda, Mark Dmytruk, è programmato per partecipare a una chiacchierata informale il venerdì 6 settembre alle 11:30 a.m. ET. Questo evento offre un'opportunità agli investitori e alle parti interessate di ottenere approfondimenti sulle strategie finanziarie e la posizione di mercato di Ginkgo Bioworks. L'azienda ha dichiarato che ulteriori dettagli, inclusi un link al webcast e la registrazione della chiacchierata informale, saranno resi disponibili sul loro sito web per le relazioni con gli investitori all'indirizzo https://investors.ginkgobioworks.com/events.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), una plataforma líder en programación celular y bioseguridad, ha anunciado su participación en la 22ª Conferencia Anual de Salud Global de Morgan Stanley. El Director Financiero de la empresa, Mark Dmytruk, participará en una charla informal el viernes 6 de septiembre a las 11:30 a.m. ET. Este evento ofrece una oportunidad para que inversores y partes interesadas obtengan información sobre las estrategias financieras y la posición en el mercado de Ginkgo Bioworks. La empresa ha indicado que se proporcionarán más detalles, incluido un enlace al webcast y la repetición de la charla informal, en su sitio web de relaciones con inversores en https://investors.ginkgobioworks.com/events.
징코 바이오웍스 홀딩스 주식회사 (NYSE: DNA), 세포 프로그래밍 및 생물안전 분야의 선두 플랫폼이 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 최고 재무 책임자(Mark Dmytruk)는 9월 6일 금요일 오전 11시 30분 ET에 화상 대화에 참여할 예정입니다. 이 이벤트는 투자자와 관심 있는 사람들이 징코 바이오웍스의 재무 전략과 시장 위치에 대한 통찰을 얻을 수 있는 기회를 제공합니다. 회사는 추가 세부정보, 웹캐스트 링크 및 화상 대화 다시보기는 투자자 관계 웹사이트인 https://investors.ginkgobioworks.com/events에서 제공될 것이라고 밝혔습니다.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), une plateforme leader en programmation cellulaire et en biosécurité, a annoncé sa participation à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. Le directeur financier de l'entreprise, Mark Dmytruk, est prévu pour participer à une discussion informelle le vendredi 6 septembre à 11h30 ET. Cet événement offre une opportunité aux investisseurs et aux parties intéressées d'obtenir des informations sur les stratégies financières et la position sur le marché de Ginkgo Bioworks. L'entreprise a déclaré que des détails supplémentaires, y compris un lien pour le webcast et un replay de la discussion informelle, seront disponibles sur leur site web de relations investisseurs à l'adresse suivante : https://investors.ginkgobioworks.com/events.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), eine führende Plattform für Zellprogrammierung und Biosicherheit, hat ihre Teilnahme an der 22. Jahreskonferenz für globale Gesundheitsversorgung von Morgan Stanley angekündigt. Der Finanzvorstand des Unternehmens, Mark Dmytruk, wird am Freitag, den 6. September um 11:30 Uhr ET an einem Gespräch teilnehmen. Diese Veranstaltung bietet eine Gelegenheit für Investoren und Interessierte, Einblicke in die Finanzstrategien und die Marktposition von Ginkgo Bioworks zu gewinnen. Das Unternehmen hat erklärt, dass weitere Details, einschließlich eines Webcast-Links und einer Wiederholung des Gesprächs, auf ihrer Investor-Relations-Website unter https://investors.ginkgobioworks.com/events verfügbar sein werden.
- Participation in a major healthcare conference, potentially increasing visibility and investor interest
- Opportunity for the CFO to present the company's financial strategies and market position
- None.
Further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302234549.html
SOURCE Ginkgo Bioworks
FAQ
When is Ginkgo Bioworks (DNA) participating in the Morgan Stanley Global Healthcare Conference?
Who will represent Ginkgo Bioworks (DNA) at the Morgan Stanley healthcare conference?
Where can I find more information about Ginkgo Bioworks' (DNA) participation in the Morgan Stanley conference?
What is the stock symbol for Ginkgo Bioworks mentioned in the press release?
